The recent 2020 draft of EU GMP Annex 1, which regulates the manufacture, control and release of sterile pharmaceutical products in the EU, signals that there are comprehensive changes to come. This webinar will outline a holistic approach to ensure continued compliance, taking into account the expected changes, including the need for EM programs and procedures based on risk analysis.
If you operate aseptic manufacturing areas or facilities, such as ISO 5 cleanrooms in a traditional set up, RABS or isolators, you should watch this on-demand webinar.
Key Learning Objectives:
BEng, Vice President of R&D – Cofounder
With 20 years of experience developing products for regulated and healthcare industries, Aram has successfully co-founded Novatek International, Novatek Medical Data Systems, Cognistat and Cognistat Sport. Aram plays an active role in the management of the Novatek Engineering Team as well as the R&D activities with a 100 percent success rate over the last 15 years. With a background in Electrical and Computer Engineering and added expertise in regulated (GAMP, GxP, etc) and niche market product development, Aram has successfully managed the development and implementation of over 18 software products ranging from thick client-server to Saas solutions to clients worldwide.
Dr. Anne-Grit Klees
Global Product Manager Environmental Monitoring
Dr. Anne-Grit Klees, is a Global Product Manager Environmental Monitoring at MilliporeSigma. She is microbiologist and graduated at Philipps Universität Marburg in 1992. After graduation she started her carreer as medical referent at Pall. Since 1994 she was working as a global product manager at Biotest, heipha Dr. Müller GmbH and MilliporeSigma with a strong expertise on environmental monitoring in pharmaceutical industries including ready to use culture media for air and surface and personnel monitoring.
Research. Development. Production.
We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.